Current Environment: Production

Marilyn G. Liang | Education

Undergraduate School

Massachusetts Institute of Technology

1990, Cambridge, MA

Medical School

University of Rochester School of Medicine

1994, Rochester, NY

Internship

Strong Memorial Hospital

1995, Rochester, NY

Residency

Pediatrics

Strong Memorial Hospital

1996, Rochester, NY

Residency

Chief Resident (1998-1999)

Mayo Clinic Foundation

1999, Rochester, MN

Marilyn G. Liang | Certifications

  • American Board of Dermatology (General)
  • American Board of Dermatology (Pediatric Dermatology)

Marilyn G. Liang | Publications

  1. Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets. J Clin Invest. 2024 Jul 23; 134(17). View Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets. Abstract

  2. Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders. JAMA Dermatol. 2024 Jun 01; 160(6):621-630. View Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders. Abstract

  3. ACR Appropriateness Criteria® Soft Tissue Vascular Anomalies: Vascular Malformations and Infantile Vascular Tumors (Non-CNS)-Child. J Am Coll Radiol. 2024 Jun; 21(6S):S310-S325. View ACR Appropriateness Criteria® Soft Tissue Vascular Anomalies: Vascular Malformations and Infantile Vascular Tumors (Non-CNS)-Child. Abstract

  4. Immunohistochemical Expression of Lymphatic Endothelial Markers in Blue Rubber Bleb Nevus Syndrome. Pediatr Dev Pathol. 2024 May-Jun; 27(3):228-234. View Immunohistochemical Expression of Lymphatic Endothelial Markers in Blue Rubber Bleb Nevus Syndrome. Abstract

  5. Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10. J Pediatr. 2024 Apr; 267:113907. View Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10. Abstract

  6. Infantile Hemangioma of the Breast: Long-Term Assessment of Outcomes. Plast Reconstr Surg Glob Open. 2024 Jan; 12(1):e5506. View Infantile Hemangioma of the Breast: Long-Term Assessment of Outcomes. Abstract

  7. Spectrum of lymphatic anomalies in patients with RASA1-related CM-AVM. Pediatr Dermatol. 2023 Nov-Dec; 40(6):1028-1034. View Spectrum of lymphatic anomalies in patients with RASA1-related CM-AVM. Abstract

  8. Non-vascular intracranial lesions in three children with PHACE association. Pediatr Dermatol. 2024 Mar-Apr; 41(2):284-288. View Non-vascular intracranial lesions in three children with PHACE association. Abstract

  9. Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Pediatr Dermatol. 2024 Jan-Feb; 41(1):76-79. View Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Abstract

  10. Paradoxical Psoriasiform Eruptions in Children Receiving Tumor Necrosis Factor a Inhibitors. JAMA Dermatol. 2023 06 01; 159(6):637-642. View Paradoxical Psoriasiform Eruptions in Children Receiving Tumor Necrosis Factor a Inhibitors. Abstract

  11. Metopic ridge presenting to pediatric dermatology and vascular anomalies clinics. Pediatr Dermatol. 2023 Jul-Aug; 40(4):657-659. View Metopic ridge presenting to pediatric dermatology and vascular anomalies clinics. Abstract

  12. Genomic analysis reveals germline and somatic PDGFRB variants with clinical implications in familial infantile myofibromatosis. Pediatr Blood Cancer. 2023 06; 70(6):e30262. View Genomic analysis reveals germline and somatic PDGFRB variants with clinical implications in familial infantile myofibromatosis. Abstract

  13. Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series. Pediatr Dermatol. 2023 Jan; 40(1):90-95. View Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series. Abstract

  14. Topical treatment of pyogenic granulomas in a pediatric population: A single-institution retrospective review. JAAD Int. 2022 Sep; 8:7-9. View Topical treatment of pyogenic granulomas in a pediatric population: A single-institution retrospective review. Abstract

  15. Kaposiform Lymphangiomatosis: Pathologic Aspects in 43 Patients. Am J Surg Pathol. 2022 07 01; 46(7):963-976. View Kaposiform Lymphangiomatosis: Pathologic Aspects in 43 Patients. Abstract

  16. Verrucous Venous Malformation-Subcutaneous Variant. Am J Dermatopathol. 2021 Dec 01; 43(12):e181-e184. View Verrucous Venous Malformation-Subcutaneous Variant. Abstract

  17. Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE Syndrome. JAMA Dermatol. 2021 06 16. View Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE Syndrome. Abstract

  18. Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies. JAMA Dermatol. 2021 02 01; 157(2):233-235. View Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies. Abstract

  19. Classification of lower extremity venous malformations and risk of knee involvement: A retrospective cohort study. J Am Acad Dermatol. 2021 12; 85(6):1480-1485. View Classification of lower extremity venous malformations and risk of knee involvement: A retrospective cohort study. Abstract

  20. Early Features of Progressive Hemifacial Atrophy-Clinical and Imaging Findings. JAMA Dermatol. 2020 12 01; 156(12):1376-1379. View Early Features of Progressive Hemifacial Atrophy-Clinical and Imaging Findings. Abstract

  21. Congenital Disseminated Pyogenic Granuloma: Characterization of an Aggressive Multisystemic Disorder. J Pediatr. 2020 11; 226:157-166. View Congenital Disseminated Pyogenic Granuloma: Characterization of an Aggressive Multisystemic Disorder. Abstract

  22. Pediatric facial pyoderma gangrenosum preceding the diagnosis of inflammatory bowel disease. Pediatr Dermatol. 2020 Jul; 37(4):764-766. View Pediatric facial pyoderma gangrenosum preceding the diagnosis of inflammatory bowel disease. Abstract

  23. Cutaneous manifestations of congenital malignant rhabdoid tumor: Unusual papillomatous plaques and other skin presentations. Pediatr Dermatol. 2020 Jul; 37(4):645-650. View Cutaneous manifestations of congenital malignant rhabdoid tumor: Unusual papillomatous plaques and other skin presentations. Abstract

  24. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants. Clin Genet. 2020 05; 97(5):736-740. View Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants. Abstract

  25. Clinical and radiological characteristics of patients with retroperitoneal infantile hemangiomas. Pediatr Dermatol. 2019 Nov; 36(6):823-829. View Clinical and radiological characteristics of patients with retroperitoneal infantile hemangiomas. Abstract

  26. Pediatric leukemia cutis: A case series. Pediatr Dermatol. 2019 Sep; 36(5):658-663. View Pediatric leukemia cutis: A case series. Abstract

  27. Herpes zoster at the vaccination site in immunized healthy children. Pediatr Dermatol. 2018 Mar; 35(2):230-233. View Herpes zoster at the vaccination site in immunized healthy children. Abstract

  28. Holmes heart and tetralogy of Fallot in association with PHACE. Pediatr Dermatol. 2018 Jan; 35(1):e39-e41. View Holmes heart and tetralogy of Fallot in association with PHACE. Abstract

  29. Internal venous anomalies in patients with a genital venous malformation. Pediatr Dermatol. 2018 Jan; 35(1):126-131. View Internal venous anomalies in patients with a genital venous malformation. Abstract

  30. A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowth. J Am Acad Dermatol. 2018 05; 78(5):1023-1025. View A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowth. Abstract

  31. Self-limited neonatal periumbilical erythema. Pediatr Dermatol. 2017 Nov; 34(6):730-731. View Self-limited neonatal periumbilical erythema. Abstract

  32. Role of imaging in the diagnosis of parotid infantile hemangiomas. Int J Pediatr Otorhinolaryngol. 2017 Nov; 102:61-66. View Role of imaging in the diagnosis of parotid infantile hemangiomas. Abstract

  33. Wilms tumor screening in diffuse capillary malformation with overgrowth and macrocephaly-capillary malformation: A retrospective study. J Am Acad Dermatol. 2017 Nov; 77(5):874-878. View Wilms tumor screening in diffuse capillary malformation with overgrowth and macrocephaly-capillary malformation: A retrospective study. Abstract

  34. Sonographic screening for Wilms tumor in children with CLOVES syndrome. Pediatr Blood Cancer. 2017 Dec; 64(12). View Sonographic screening for Wilms tumor in children with CLOVES syndrome. Abstract

  35. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth. Angiogenesis. 2017 Aug; 20(3):303-306. View A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth. Abstract

  36. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr. 2016 11; 178:24-33.e2. View PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. Abstract

  37. Effect of Angiofibromas on Quality of Life and Access to Care in Tuberous Sclerosis Patients and Their Caregivers. Pediatr Dermatol. 2016 Sep; 33(5):518-25. View Effect of Angiofibromas on Quality of Life and Access to Care in Tuberous Sclerosis Patients and Their Caregivers. Abstract

  38. Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. Circulation. 2016 Jul 12; 134(2):114-25. View Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. Abstract

  39. A Widespread Pruritic Rash With Facial Swelling and Black Streaks. JAMA Pediatr. 2016 06 01; 170(6):617-8. View A Widespread Pruritic Rash With Facial Swelling and Black Streaks. Abstract

  40. Gastrointestinal Infantile Hemangioma: Presentation and Management. J Pediatr Gastroenterol Nutr. 2015 Oct; 61(4):415-20. View Gastrointestinal Infantile Hemangioma: Presentation and Management. Abstract

  41. Impact of Screening for Hepatic Hemangiomas in Patients with Multiple Cutaneous Infantile Hemangiomas. Pediatr Dermatol. 2015 Nov-Dec; 32(6):808-12. View Impact of Screening for Hepatic Hemangiomas in Patients with Multiple Cutaneous Infantile Hemangiomas. Abstract

  42. Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations. JAMA Dermatol. 2015 Jun; 151(6):627-34. View Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations. Abstract

  43. Capillary-venous malformation in the upper limb. Pediatr Dermatol. 2015 Mar-Apr; 32(2):287-9. View Capillary-venous malformation in the upper limb. Abstract

  44. Diffuse capillary malformation in association with fetal pleural effusion: report of five patients. Pediatr Dermatol. 2015 Jan-Feb; 32(1):70-5. View Diffuse capillary malformation in association with fetal pleural effusion: report of five patients. Abstract

  45. Rapidly involuting congenital hemangioma with fetal involution. Pediatr Dermatol. 2015 May-Jun; 32(3):321-6. View Rapidly involuting congenital hemangioma with fetal involution. Abstract

  46. Infantile and congenital hemangiomas. Semin Pediatr Surg. 2014 Aug; 23(4):162-7. View Infantile and congenital hemangiomas. Abstract

  47. Frequency of ear symptoms and hearing loss in ichthyosis: a pilot survey study. Pediatr Dermatol. 2014 May-Jun; 31(3):276-80. View Frequency of ear symptoms and hearing loss in ichthyosis: a pilot survey study. Abstract

  48. Growth hormone replacement in patients with PHACE association and hypopituitarism. Pediatr Dermatol. 2014 May-Jun; 31(3):337-40. View Growth hormone replacement in patients with PHACE association and hypopituitarism. Abstract

  49. Pediatric melanoma, moles, and sun safety. Pediatr Clin North Am. 2014 Apr; 61(2):279-91. View Pediatric melanoma, moles, and sun safety. Abstract

  50. Initial cutaneous manifestations of Hutchinson-Gilford progeria syndrome. Pediatr Dermatol. 2014 Mar-Apr; 31(2):196-202. View Initial cutaneous manifestations of Hutchinson-Gilford progeria syndrome. Abstract

  51. Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. J Am Acad Dermatol. 2013 Oct; 69(4):589-94. View Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. Abstract

  52. Capillary-venous malformation in the lower limb. Pediatr Dermatol. 2013 Sep-Oct; 30(5):541-8. View Capillary-venous malformation in the lower limb. Abstract

  53. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2012 Oct 09; 109(41):16666-71. View Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Abstract

  54. Picture of the month-quiz case. Infantile Fibrosarcoma. Arch Pediatr Adolesc Med. 2012 Sep; 166(9):863. View Picture of the month-quiz case. Infantile Fibrosarcoma. Abstract

  55. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013 Jan; 162(1):142-7. View Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. Abstract

  56. Pathogenesis of infantile hemangiomas. Pediatr Ann. 2012 Aug; 41(8):1-6. View Pathogenesis of infantile hemangiomas. Abstract

  57. Sweet syndrome in children. Pediatr Dermatol. 2012 Jan-Feb; 29(1):38-44. View Sweet syndrome in children. Abstract

  58. Severe atopic dermatitis and transient hypogammaglobulinemia in children. Pediatr Dermatol. 2012 Jan-Feb; 29(1):73-8. View Severe atopic dermatitis and transient hypogammaglobulinemia in children. Abstract

  59. Management of capillary malformations. Clin Plast Surg. 2011 Jan; 38(1):65-73. View Management of capillary malformations. Abstract

  60. Vascular malformations. Pediatr Clin North Am. 2010 Oct; 57(5):1091-110. View Vascular malformations. Abstract

  61. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr. 2010 Nov; 157(5):795-801.e1-7. View LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. Abstract

  62. Terminology used to describe vascular anomalies. Arch Pediatr Adolesc Med. 2010 Feb; 164(2):203-4; author reply 204-5. View Terminology used to describe vascular anomalies. Abstract

  63. A Chronic Rash with a "Wood Grain" Pattern on the Extremities. Socieity for Pediatric Dermatology. Snowbird, UT. 2008.

  64. Diffuse Capillary Malformation with Proportionate Overgrowth: Characterization of a Disorder Distinct from Defined Overgrowth Syndromes. 17th International Workshop on Vascular Anomalies. Boston, MA. 2008.

  65. Glucose transporter-1 protein is immunohistochemically expressed in subglottic infantile haemangioma. Br J Dermatol. 2008 Apr; 158(4):862-3. View Glucose transporter-1 protein is immunohistochemically expressed in subglottic infantile haemangioma. Abstract

  66. What syndrome is this? Laryngo-onycho-cutaneous syndrome. Pediatr Dermatol. 2007 May-Jun; 24(3):306-8. View What syndrome is this? Laryngo-onycho-cutaneous syndrome. Abstract

  67. Vascular Anomalies. Zaoutis LB, Chiang VW, editors. Comprehensive Pediatric Hospital Medicine. 2007; 971-975.

  68. Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Pediatrics. 2006 Nov; 118(5):e1593-9. View Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Abstract

  69. Celiac disease presenting with chilblains in an adolescent girl. Pediatr Dermatol. 2006 Sep-Oct; 23(5):451-4. View Celiac disease presenting with chilblains in an adolescent girl. Abstract

  70. Hypopituitarism in PHACES Association. Pediatr Dermatol. 2006 Sep-Oct; 23(5):476-80. View Hypopituitarism in PHACES Association. Abstract

  71. Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma. Pediatr Dermatol. 2006 Jul-Aug; 23(4):330-4. View Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma. Abstract

  72. Genuine diffuse phlebectasia of Bockenheimer: dissection of an eponym. Pediatr Dermatol. 2006 May-Jun; 23(3):294-7. View Genuine diffuse phlebectasia of Bockenheimer: dissection of an eponym. Abstract

  73. Congenital Cutaneous Mastocytosis. New England Dermatological Society. Boston, MA. 2006.

  74. Pediatric Sweet Syndrome: A Case Series. Society for Pediatric Dermatology. Montreal, Canada. 2006.

  75. What syndrome is this? Sjögren-Larsson syndrome. Pediatr Dermatol. 2005 Nov-Dec; 22(6):569-71. View What syndrome is this? Sjögren-Larsson syndrome. Abstract

  76. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol. 2005 Nov; 18(11):1454-60. View D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Abstract

  77. Cutaneovisceral angiomatosis with thrombocytopenia. Pediatr Dev Pathol. 2005 Jul-Aug; 8(4):407-19. View Cutaneovisceral angiomatosis with thrombocytopenia. Abstract

  78. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol. 2005 Apr; 52(4):616-22. View Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. Abstract

  79. Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. J Am Acad Dermatol. 2004 Nov; 51(5):718-22. View Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. Abstract

  80. "But they told us she had a hemangioma....". Contemp Pediatr. 2004; 21(7):51-67..

  81. Laryngo-onycho-cutaneous Syndrome in a Pakistani Female. Society for Pediatric Dermatology, Charleston, SC. 2004.

  82. Accuracy in Terminology, Diagnosis and Management for Referrals to a Vascular Anomalies Center. International Society for the Study of Vascular Anomalies. Wellington, New Zealand. 2004.

  83. Congenital Infantile Fibrosarcoma Masquerading as an Ulcerated Hemangioma of Infancy. International Society for the Study of Vascular Anomalies. Wellington, New Zealand. 2004.

  84. PHACE Syndrome. Atlantic Dermatological Society Clinical Meeting. Boston, MA. 2004.

  85. Cystic Fibrosis Presenting as a Diffuse Erythematous Scaly Eruption. Society for Pediatric Dermatology. Seattle, WA. 2003.

  86. The Spectrum of Mycobacterial Infection in Patients with Immunodeficiency and NFkB Essential Modifier (NEMO) Mutation with or without Ectodermal Dysplasia. Society for Pediatric Dermatology. Seattle, WA. 2003.

  87. Congenital Infantile Fibrosarcoma Masquerading as an Ulcerated Congenital Hemangioma. Society for Pediatric Dermatology. Seattle, WA. 2003.

  88. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol. 2003 Jun; 25(3):183-9. View Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Abstract

  89. Fibroblastic rheumatism: case report and review of the literature. Pediatr Dermatol. 2002 Nov-Dec; 19(6):532-5. View Fibroblastic rheumatism: case report and review of the literature. Abstract

  90. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol. 2002 Oct; 47(4):505-11. View Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. Abstract

  91. Perineal ulcerations as the presenting manifestation of hemangioma. Arch Dermatol. 2002 Jan; 138(1):126-7. View Perineal ulcerations as the presenting manifestation of hemangioma. Abstract

  92. Oral lesions. Parish LC, Brenner S, Ramos-e-Silva M, editors. Women’s dermatology: from infancy to maturity. 2001; 353-361.

  93. Acral Papules, Polyarthritis and Induration of the Skin. Society for Pediatric Dermatology. Sante Fe, NM. 2000.

  94. Progeria. Society for Pediatric Dermatology. San Francisco, CA. 2000.

  95. Cutaneous inoculation tuberculosis in a child. J Am Acad Dermatol. 1999 Nov; 41(5 Pt 2):860-2. View Cutaneous inoculation tuberculosis in a child. Abstract

  96. Familial Annular Erythema. Society for Pediatric Dermatology. New Orleans, LA. 1999.

  97. Cutaneous Tuberculosis in a Child. Society for Pediatric Dermatology. Boston, MA. 1998.

  98. Herpes Zoster Following Varicella Vaccination. Annales de Dermatologie et de Venereologie. 8th International Congress Pediatric Dermatology. Paris, France. 1998; 125:1S84.

  99. Herpes zoster after varicella immunization. J Am Acad Dermatol. 1998 May; 38(5 Pt 1):761-3. View Herpes zoster after varicella immunization. Abstract

  100. Treatment of confluent and reticulated papillomatosis of Gougerot et Carteaud with minocycline. J Dermatol Treat. 1998; 9:115-117.

  101. Progressive Port-wine Stain in Phakomatosis Pigmentovascularis Type IIIa. Society for Pediatric Dermatology. Sun Valley, ID. 1997.

  102. Perineal and lip ulcerations as the presenting manifestation of hemangioma of infancy. Pediatrics. 1997 Feb; 99(2):256-9. View Perineal and lip ulcerations as the presenting manifestation of hemangioma of infancy. Abstract

BESbswy
BESbswy